Medtronic Gets U.S. FDA Approval for MiniMed 770G System

Medtronic’s MiniMed 770G System was approved by the U.S. Food and Drug Administration, which cited the device as the first automated insulin delivery and monitoring system for use in young pediatric patients.

• The FDA evaluated data from a clinical trial that included 46 children aged 2 to 6 years old with type 1 diabetes, according to a statement on the agency’s website
• Requiring a post-market study to evaluate device performance in real-world settings in children between the ages of 2 and 6

To view the source of this information click here

To contact the reporter on this story:
Greg Chang ...